4
Changes in Ownership
Evommune, Inc. Filed Acc 0002092017-26-000005
Chief Scientific Officer sold 16,687 shares at $22.74 ($379,462)
- Chief Scientific Officer acquired 13,512 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-01 | Option exercise 10b5-1 | +13,512 | $3.84 | $51,886 | 63,090 | D: show line 1 in the form |
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-01 | Sale 10b5-1 | −16,687 | $22.74 | $379,462 | 46,403 | D: show line 2 in the form |
| Open-market sales · 16,687 sh · avg $22.74 · $379,462 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-06-01 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −13,512 | 29,330 | D: show line 3 in the form |
Loading xslF345X06/primarydocument.xml…